.jpg)
TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER
Patent number:
WO21009029
No items found.
Compounds of formula (I) of the betaxanthin family, or pharmaceutical compositions comprising the same, for use in the treatment and/or prevention of cancer and/or tumours, are described. In addition, the use of nutraceutical compositions, for the prevention of cancer or as chemopreventive compositions, comprising said compounds of formula (I) is described.
Countries:
Spain
Regions:
Region of Murcia
Centers:
UNIVERSIDAD DE MURCIA
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals, Organic fine chemistry
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
- Obtaining larger amounts of betaxanthins compared to other methods used. - Obtaining pure betaxanthins with antitumor properties tested in the C. Elegans animal model.
Comments
Other related patents
Health
Printing system for obtaining free-form width-controlled individual biological fibers
Health
Chemicals
Aerospace
Automotive & Rail
Textile
PROGRAM METHOD, SYSTEM AND PRODUCT FOR INTERACTION IN VIRTUAL REALITY ENVIRONMENTS THROUGH A HAPTIC DESKTOP FORCES FEEDBACK DEVICE
Health